Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 2
2010 2
2011 1
2012 1
2013 1
2014 2
2015 1
2016 3
2017 2
2018 3
2019 3
2020 4
2021 8
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Titanium oxide nano-radiosensitizers for hydrogen peroxide delivery into cancer cells.
Morita K, Nishimura Y, Nakamura S, Arai Y, Numako C, Sato K, Nakayama M, Akasaka H, Sasaki R, Ogino C, Kondo A. Morita K, et al. Among authors: sato k. Colloids Surf B Biointerfaces. 2021 Feb;198:111451. doi: 10.1016/j.colsurfb.2020.111451. Epub 2020 Nov 7. Colloids Surf B Biointerfaces. 2021. PMID: 33223346
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Kobayashi K, Toyoda M, Hatori N, Sakai H, Furuki T, Chin K, Kimura M, Saito N, Kanaoka T, Aoyama T, Umezono T, Ito S, Suzuki D, Takeda H, Minagawa F, Degawa H, Machimura H, Hishiki T, Umezawa S, Shimura H, Nakajima S, Yamamoto H, Sato K, Miyakawa M, Terauchi Y, Tamura K, Kanamori A. Kobayashi K, et al. Among authors: sato k. Diabetes Res Clin Pract. 2022 Mar;185:109231. doi: 10.1016/j.diabres.2022.109231. Epub 2022 Feb 5. Diabetes Res Clin Pract. 2022. PMID: 35131376
Concomitant treatment with insulin and sodium-glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score-matched analysis.
Toyoda M, Saito N, Kimura M, Hatori N, Tamura K, Miyakawa M, Sato K, Kanamori A, Kobayashi K. Toyoda M, et al. Among authors: sato k. J Diabetes Investig. 2022 Sep;13(9):1520-1527. doi: 10.1111/jdi.13825. Epub 2022 May 20. J Diabetes Investig. 2022. PMID: 35524473 Free PMC article.
The Comparison of the Kidney Effects of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide 1 Agonist-Administered Concomitant with Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Kobayashi K, Toyoda M, Hatori N, Sato K, Miyakawa M, Tamura K, Kanamori A. Kobayashi K, et al. Among authors: sato k. J Diabetes Res. 2021 Dec 21;2021:6573369. doi: 10.1155/2021/6573369. eCollection 2021. J Diabetes Res. 2021. PMID: 35028319 Free PMC article.
39 results